alexa From Lung Cancer Screening to Targeted Therapies: The Endless Race against Lung Cancer Morbidity and Mortality | OMICS International| Abstract
ISSN: 2576-1447

Journal of Cancer Science and Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
  • Editorial   
  • J Can Sci Res ,
  • DOI: 10.4172/2576-1447.1000S1-e001

From Lung Cancer Screening to Targeted Therapies: The Endless Race against Lung Cancer Morbidity and Mortality

Alexander Mathioudakis1 and Georgia Hardavella2*
1ERS Guidelines Methodology Fellow, Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, , Barcelona, Spain
2Consultant Respiratory Physician, Department of Respiratory Medicine, Kings College Hospital, , London, UK
*Corresponding Author : Georgia Hardavella MD, MSc, PhD, Consultant Respiratory Physician, Department of Respiratory Medicine, Kings College Hospital, London, UK, Tel: +44(0)7928471770, Email: [email protected]

Received Date: Jun 27, 2016 / Accepted Date: Jun 28, 2016 / Published Date: Jun 30, 2016

Citation: Mathioudakis A, Hardavella G (2016) From Lung Cancer Screening to Targeted Therapies: The Endless Race against Lung Cancer Morbidity and Mortality. J Lung Cancer Diagn Treat S1: e101. Doi: 10.4172/2576-1447.1000S1-e001

Copyright: © 2016 Mathioudakis A et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 622
  • [From(publication date): 0-2018 - Jun 20, 2019]
  • Breakdown by view type
  • HTML page views: 578
  • PDF downloads: 44
Leave Your Message 24x7
Top